middle.news

TrivarX Engages CRO Beyond for Stabl-Im Phase 1 Safety Trial

10:00am on Thursday 1st of January, 1970 AEST Healthcare
Read Story

TrivarX Engages CRO Beyond for Stabl-Im Phase 1 Safety Trial

10:00am on Thursday 1st of January, 1970 AEST
Key Points
  • Beyond Drug Development appointed for Phase 1 trial
  • Stabl-Im uses stable isotopes for tumour imaging
  • Phase 1 focuses on safety in healthy volunteers
  • Trial start targeted for second half of 2026
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Trivarx (ASX:TRI)
OPEN ARTICLE